Abel de la Rosa

Abel de la Rosa

Direktor/Vorstandsmitglied bei VIRIOS THERAPEUTICS, INC.

61 Jahre
Health Technology
Consumer Services
Commercial Services

Ursprung des Netzwerks ersten Grades von Abel de la Rosa

EinheitArt der EinheitIndustrie
24
Subsidiary Pharmaceuticals: Other 24
12
Extinct Pharmaceuticals: Major 12
Public Company Pharmaceuticals: Major 11
8
Private Company Pharmaceuticals: Major 8

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Abel de la Rosa

UnternehmenSektorVerknüpfte PersonenHauptposition
GILEAD SCIENCES, INC. Biotechnology

Richard Whitley

William T. Symonds

Michael Sofia

Director/Board Member

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Gregory Duncan

Richard Burch

Sales & Marketing

Corporate Officer/Principal

REGENERON PHARMACEUTICALS, INC. Pharmaceuticals: Major

Paul F. Lubetkin

Fredric D. Price

General Counsel

Director of Finance/CFO

BIOMARIN PHARMACEUTICAL INC. Biotechnology

Ansbert Gadicke

Fredric D. Price

Director/Board Member

Chief Executive Officer

IDENIX PHARMACEUTICALS INC Pharmaceuticals: Major

Ansbert Gadicke

Alexandra Goll

Douglas L. Mayers

Director/Board Member

Director/Board Member

Chief Tech/Sci/R&D Officer

Investment Managers

Richard E. T. Smith

Analyst-Equity

CHIMERIX, INC. Pharmaceuticals: Major

M. Berrey

Michael D. Rogers

Chief Executive Officer

Corporate Officer/Principal

Biotechnology

Loni da Silva

Keith Westby

General Counsel

Corporate Officer/Principal

Miscellaneous Commercial Services

Herbert Conrad

Patrick T. Higgins

President

Sales & Marketing

CELATOR PHARMACEUTICALS INC Pharmaceuticals: Major

Nicole Vitullo

Scott Morenstein

Director/Board Member

Director/Board Member

CHIASMA, INC. Pharmaceuticals: Major

Ansbert Gadicke

Fredric D. Price

Director/Board Member

Chairman

Pharmaceuticals: Major

Ansbert Gadicke

Fredric D. Price

Director/Board Member

Chairman

ARBUTUS BIOPHARMA CORPORATION Pharmaceuticals: Major

Herbert Conrad

Patrick T. Higgins

William T. Symonds

Michael Sofia

Michael McElhaugh

Director/Board Member

Chief Operating Officer

Director/Board Member

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Biotechnology

P. Schaefer Price

Patrick T. Higgins

William T. Symonds

Michael Sofia

Michael McElhaugh

Director/Board Member

Founder

Director/Board Member

Founder

Chief Executive Officer

GSK PLC Pharmaceuticals: Major

M. Berrey

Michael D. Rogers

Corporate Officer/Principal

Corporate Officer/Principal

University of Pennsylvania College/University

Douglas L. Mayers

Scott Morenstein

Doctorate Degree

Undergraduate Degree

University of Oxford College/University

Richard E. T. Smith

Doctorate Degree

Biotechnology

Loni da Silva

Patrick T. Higgins

General Counsel

Sales & Marketing

Miscellaneous Commercial Services

John Thomas

William P. Reddick

Richard Eiswirth

Angela Walsh

Comptroller/Controller/Auditor

Corporate Officer/Principal

Corporate Officer/Principal

Comptroller/Controller/Auditor

Emory University College/University

M. Berrey

William J. Carney

Ralph Grosswald

Gregory Duncan

Graduate Degree

Corporate Officer/Principal

Corporate Officer/Principal

Masters Business Admin

College/University

Robert Williamson

Craig David Gordon

Abel de la Rosa

Corporate Officer/Principal

Doctorate Degree

Doctorate Degree

University of Wisconsin College/University

G. Steven Burrill

P. Schaefer Price

Mark W. Meester

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Biotechnology

Ansbert Gadicke

Khalil Barrage

Director/Board Member

Director/Board Member

College/University

Craig David Gordon

Michael Sofia

Undergraduate Degree

Undergraduate Degree

University of California, Davis College/University

Michael K. Inouye

Michael R. Hanley

Undergraduate Degree

Corporate Officer/Principal

IVERIC BIO, INC. Pharmaceuticals: Generic

Loni da Silva

Keith Westby

General Counsel

Chief Operating Officer

Biotechnology

Ansbert Gadicke

Gregory Mayes

Director/Board Member

Chief Executive Officer

Seton Hall University College/University

Patrick T. Higgins

Patricia Snyder-Johnson

Masters Business Admin

Undergraduate Degree

College/University

William P. Reddick

Robert Buchalter

Graduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Robert Williamson

Ansbert Gadicke

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

G. Steven Burrill

Gregory Mayes

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

Alan Roemer

William T. Symonds

Corporate Officer/Principal

Corporate Officer/Principal

Wake Forest University College/University

Richard Eiswirth

Angela Walsh

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Alan Roemer

Director of Finance/CFO

Rollins School of Public Health College/University

Alan Roemer

Graduate Degree

IN8BIO, INC. Biotechnology

Alan Roemer

Chairman

University of Leeds College/University

Richard E. T. Smith

Undergraduate Degree

Yale University College/University

William J. Carney

Graduate Degree

BLUEBIRD BIO, INC. Biotechnology

Richard E. T. Smith

Investor Relations Contact

Miscellaneous Commercial Services

William J. Carney

Corporate Officer/Principal

Miscellaneous Commercial Services

William J. Carney

Corporate Officer/Principal

Miscellaneous Commercial Services

Alan Roemer

Director/Board Member

University of Wyoming College/University

William J. Carney

Corporate Officer/Principal

Biotechnology

Alan Roemer

Director/Board Member

Statistik

International

Vereinigte Staaten 41
Vereinigtes Königreich 5
Italien 2
Kanada 2

Sektoral

Health Technology 25
Consumer Services 15
Commercial Services 8
Finance 2

Operativ

Director/Board Member 259
Corporate Officer/Principal 112
Independent Dir/Board Member 50
Undergraduate Degree 41
Chairman 40
  1. Börse
  2. Insiders
  3. Abel de la Rosa
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT